Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
In sweeping changes to the childhood vaccine schedule, the Centers for Disease Control and Prevention no longer recommends ...
Sanofi's acquisition of Dynavax, valued at $2.2 billion, aims to enhance its vaccine portfolio, including a promising shingles vaccine candidate, Z-1018. Z-1018 has demonstrated comparable ...
Here's what you need to know about the federal government's new vaccine recommendations.
The CDC announced Monday an unprecedented overhaul of the childhood vaccine schedule that recommends fewer shots to all children.
Do your own analysis; you don’t need a degree in science: Read the document and see if you can find any estimates of whether ...
Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...
The Trump administration this week adjusted down the recommended children's vaccination schedule.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results